Boston’s life sciences market continues to feel pain, and researchers and brokers say it could be some time before it is back to full health. Layoffs in the biotech industry accelerated last quarter, and companies continued to cut their real estate footprints and put hundreds of thousands of square feet back on the market, new reports from CBRE and JLL found. 
The Greater Boston life sciences market recorded 445K SF of negative net absorption last quarter, its second consecutive quarter of occupancy losses, as more companies added sublease space to the market, according to CBRE’s Boston Metro Lab report. The driving factor for this was the lack of funding and capital for these companies,… Read the full story here. | 
